BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 81712)

  • 1. Ovarian tumor antigens.
    Bhattacharya M; Barlow JJ
    Cancer; 1978 Sep; 42(3 Suppl):1616-20. PubMed ID: 81712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated antigen for cystadenocarcinomas of the ovary.
    Bhattacharya M; Barlow JJ
    Natl Cancer Inst Monogr; 1975 Oct; 42():25-32. PubMed ID: 825781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA-125 in gynecological malignancies.
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-associated antigens in female genital tract cancers.
    Harlozinska A; Kula J; Stepinska B; Jelen M; Richter R
    Tumori; 1984 Jun; 70(3):281-9. PubMed ID: 6204430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian tumor antigens: preliminary histological investigation.
    Daunter B; Jaa-Kwee D; Miklosi S; Wright G
    Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
    Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
    J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers for ovarian cancer.
    Bhattacharya M; Barlow JJ
    Int Adv Surg Oncol; 1979; 2():155-76. PubMed ID: 95453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3.
    Gangopadhyay A; Bhattacharya M; Chatterjee SK; Barlow JJ; Tsukada Y
    Cancer Res; 1985 Apr; 45(4):1744-52. PubMed ID: 3884144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer.
    Tagliabue E; Mènard S; Della Torre G; Barbanti P; Mariani-Costantini R; Porro G; Colnaghi MI
    Cancer Res; 1985 Jan; 45(1):379-85. PubMed ID: 3965146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common antigenic component in ovarian carcinomas: demonstration by double diffusion and immunofluorescence techniques.
    Dorsett BH; Ioachim HL
    Immunol Commun; 1973; 2(2):173-84. PubMed ID: 4125449
    [No Abstract]   [Full Text] [Related]  

  • 18. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
    Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of tumor-specific antigens in human mucinous cystadenocarcinoma of the ovary by immunodiffusion.
    Chow SN; Chiang WT; Wei PY
    Int J Gynaecol Obstet; 1976; 14(3):280-4. PubMed ID: 13019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
    de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.